Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging

Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging

PURPOSE. Centripetal retinal degeneration in choroideremia (CHM) leads to early visual field restriction and late central vision loss. The latter marks an acute decline in quality of life but visual prognostication remains challenging. We investigated visual function in CHM by correlating best-corre...

Bibliográfalaš dieđut
Váldodahkkit:	Jolly, J, Xue, K, Edwards, T, Groppe, M, MacLaren, R
Materiálatiipa:	Journal article
Almmustuhtton:	Association for Research in Vision and Ophthalmology 2017

Geahča maid

Visual acuity after retinal gene therapy for Choroideremia
Dahkki: Edwards, T, et al.
Almmustuhtton: (2016)

Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
Dahkki: Taylor, LJ, et al.
Almmustuhtton: (2023)

Microperimetry hill of vision and volumetric measures of retinal sensitivity
Dahkki: Josan, AS, et al.
Almmustuhtton: (2021)

Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa
Dahkki: Wood, LJ, et al.
Almmustuhtton: (2021)

The spectrum of CHM gene mutations in choroideremia and their relationship to clinical phenotype
Dahkki: Simunovic, M, et al.
Almmustuhtton: (2016)

Retinal degeneration in choroideremia follows an exponential decay function
Dahkki: Aylward, J, et al.
Almmustuhtton: (2018)

The effects of pupil dilation on MAIA microperimetry
Dahkki: Jolly, J, et al.
Almmustuhtton: (2017)

Functional defects in color vision in patients with choroideremia
Dahkki: Jolly, J, et al.
Almmustuhtton: (2015)

Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review
Dahkki: Buckley, TMW, et al.
Almmustuhtton: (2021)

Test‐retest repeatability of microperimetry in patients with retinitis pigmentosa caused by mutations in RPGR
Dahkki: Buckley, TMW, et al.
Almmustuhtton: (2020)

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Dahkki: Xue, K, et al.
Almmustuhtton: (2018)

Macular hole surgery in patients with end-stage choroideremia
Dahkki: Zinkernagel, MS, et al.
Almmustuhtton: (2013)

A detailed in vivo analysis of the retinal nerve fibre layer in choroideremia
Dahkki: Fu, D, et al.
Almmustuhtton: (2018)

Measuring Central Retinal Sensitivity Using Microperimetry
Dahkki: Talib, M, et al.
Almmustuhtton: (2017)

Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial
Dahkki: MacLaren, R, et al.
Almmustuhtton: (2014)

Correlation of optical coherence tomography and autofluorescence in the outer retina and choroid of patients with choroideremia
Dahkki: Xue, K, et al.
Almmustuhtton: (2016)

A qualitative and quantitative assessment of fundus autofluorescence patterns in patients with choroideremia
Dahkki: Jolly, J, et al.
Almmustuhtton: (2016)

Inner retinal thickening affects microperimetry thresholds in the presence of photoreceptor thinning in patients with RPGR retinitis pigmentosa
Dahkki: Jolly, JK, et al.
Almmustuhtton: (2020)

Microperimetry reliability assessed from fixation performance
Dahkki: Josan, AS, et al.
Almmustuhtton: (2023)

Optimising testing strategies when conducting MAIA microperimetry: MAIA optimisation and evolution
Dahkki: Jolly, J, et al.
Almmustuhtton: (2018)

Choroideremia: molecular mechanisms and development of AAV gene therapy
Dahkki: Patrício, M, et al.
Almmustuhtton: (2018)

Gene therapy for retinal dystrophies
Dahkki: Issa, P, et al.
Almmustuhtton: (2012)

Macular hole surgery in patients with end-stage choroideremia.
Dahkki: Zinkernagel, MS, et al.
Almmustuhtton: (2013)

Technique of retinal gene therapy: delivery of viral vector into the subretinal space
Dahkki: Xue, K, et al.
Almmustuhtton: (2017)

Novel non-contiguous exon duplication in choroideremia
Dahkki: Edwards, T, et al.
Almmustuhtton: (2017)

Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector.
Dahkki: Barnard, A, et al.
Almmustuhtton: (2014)

Low‐contrast visual acuity versus low‐luminance visual acuity in choroideremia
Dahkki: Wood, L, et al.
Almmustuhtton: (2020)

Optimisation of dark adaptation time required for mesopic microperimetry
Dahkki: Han, R, et al.
Almmustuhtton: (2018)

Characterizing visual fields in RPGR related retinitis pigmentosa using octopus static-automated perimetry
Dahkki: Buckley, TMW, et al.
Almmustuhtton: (2022)

Prenylation of rab6a as a potency assay for choroideremia gene therapy
Dahkki: Patricio, M, et al.
Almmustuhtton: (2017)

Structural and functional characteristics of color vision changes in choroideremia
Dahkki: Jolly, JK, et al.
Almmustuhtton: (2021)

Longitudinal study to assess the quantitative use of fundus autofluorescence for monitoring disease progression in choroideremia
Dahkki: Dubis, AM, et al.
Almmustuhtton: (2021)

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
Dahkki: Han, RC, et al.
Almmustuhtton: (2021)

Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy.
Dahkki: Simunovic, M, et al.
Almmustuhtton: (2017)

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.
Dahkki: Maclaren, R, et al.
Almmustuhtton: (2014)

AAV2/2-CBA-REP1 Vector with WPRE Provides Functional Expression of the Transgene in Choroideremia Mouse Knock-Out and Patient Cells
Dahkki: Tolmachova, T, et al.
Almmustuhtton: (2012)

Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration.
Dahkki: Chen, F, et al.
Almmustuhtton: (2009)

Ocular gene therapy for choroideremia: clinical trials and future perspectives
Dahkki: Xue, K, et al.
Almmustuhtton: (2018)

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
Dahkki: Halioua-Haubold, C, et al.
Almmustuhtton: (2018)

Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases
Dahkki: Xue, K, et al.
Almmustuhtton: (2020)